Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma
- 16:45 - 17:45
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
-
+
MA08.01 - Chair
16:45 - 16:45 | Presenter: Keith M Kerr
- Abstract
No abstract available for this presentation
-
+
MA08.02 - Chair
16:45 - 16:45 | Presenter: Teh-Ying Chou
- Abstract
No abstract available for this presentation
-
+
MA08.03 - Immunotherapy Alone or with Chemotherapy in Advanced NSCLC? Utility of Clinical Factors and Blood-Based Host Immune Profiling
16:45 - 16:50 | Presenter: Wallace Akerley
- Abstract
Loading... -
+
MA08.04 - LIPI and Outcomes of Durvalumab as Consolidation Therapy after ChRT in Patients with Locally-Advanced NSCLC
16:50 - 16:55 | Presenter: Mariona Riudavets
- Abstract
Loading... -
+
MA08.05 - High Concordance in Scoring PD-L1 in NSCLC Using the Roche Digital Pathology uPath system and PD-L1 Assessment Algorithm
16:55 - 17:00 | Presenter: Alexander Haragan
- Abstract
Loading... -
+
MA08.06 - Stratifying PD-L1 Expression Level Based on Multimodal Genomic Features for the Prediction of Immunotherapy Benefit in NSCLC
17:00 - 17:05 | Presenter: Yue Li
- Abstract
Loading... -
+
MA08.07 - Discussant
17:05 - 17:10 | Presenter: Wendy Cooper
- Abstract
No abstract available for this presentation
-
+
MA08.08 - Implementation of Diagnostic Biomarker Testing in Lung Cancer: Real-World Data in Japan
17:10 - 17:15 | Presenter: Yasushi Yatabe
- Abstract
Loading... -
+
MA08.09 - Clinical Management of Lung Adenocarcinoma Patients With HER2 V659E Mutation
17:15 - 17:20 | Presenter: Ziqi Jia
- Abstract
Loading... -
+
MA08.10 - LUNGMAP Master Protocol (LUNGMAP): Concordance Between Plasma ctDNA and Tissue Molecular Analysis
17:20 - 17:25 | Presenter: Philip Christopher Mack
- Abstract
Loading... -
+
MA08.11 - Identification of Clinical Features to Predict the Consistency of Mutational Profiles Obtained From Plasma and Tissue of Advanced NSCLC Patient
17:25 - 17:30 | Presenter: Yuansheng Zang
- Abstract
Loading... -
+
MA08.12 - Discussant
17:30 - 17:35 | Presenter: Lukas Bubendorf
- Abstract
No abstract available for this presentation
-
+
MA08.13 - Live Q&A
17:35 - 17:45
- Abstract
No abstract available for this presentation
-
+
PS02 - Presidential Symposium (Re-Broadcast) (Japanese, Mandarin, Spanish Translation Available)
- 18:00 - 20:00
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
-
+
PS02.01 - Welcome Video
18:00 - 18:02
- Abstract
No abstract available for this presentation
-
+
PS02.02 - National Lung Cancer Screening Program in Taiwan: The TALENT Study
18:02 - 18:12 | Presenter: Pan-Chyr Yang
- Abstract
Loading... -
+
PS02.03 - Discussant
18:12 - 18:20 | Presenter: Ugo Pastorino
- Abstract
No abstract available for this presentation
-
+
PS02.04 - International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results
18:20 - 18:30 | Presenter: Silvia Novello
- Abstract
Loading... -
+
PS02.05 - Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
18:30 - 18:40 | Presenter: Jay M. Lee
- Abstract
Loading... -
+
PS02.06 - Discussant
18:40 - 18:50 | Presenter: Shinichi Toyooka
- Abstract
No abstract available for this presentation
-
+
PS02.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non-small Cell Lung Cancer
18:50 - 19:00 | Presenter: Bob T. Li
- Abstract
Loading... -
+
PS02.08 - Discussant
19:00 - 19:08 | Presenter: Pasi Antero Jänne
- Abstract
No abstract available for this presentation
-
+
PS02.09 - Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598
19:08 - 19:18 | Presenter: Michael Boyer
- Abstract
Loading... -
+
PS02.10 - Discussant
19:18 - 19:26 | Presenter: Yun Fan
- Abstract
No abstract available for this presentation
-
+
PS02.11 - Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial
19:26 - 19:36 | Presenter: Dean Fennell
- Abstract
Loading... -
+
PS02.12 - Discussant
19:36 - 19:44 | Presenter: Rina Hui
- Abstract
No abstract available for this presentation
-
+
PS02.13 - Live Q&A
19:44 - 20:00
- Abstract
No abstract available for this presentation
-
+
PS02.14 - Chair
18:00 - 18:00 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation
first
prev